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The cAMP response protein (CRP) is a transcription factor known to
regulate many genes in Escherichia coli. Computational studies of
transcription factor binding to DNA are usually based on a simple
matrix model of sequence-dependent binding energy. For CRP, this
model predicts many binding sites that are not known to be
functional. If they are indeed spurious, the underlying binding
model is called into question. We use a species comparison method
to assess the functionality of a population of such predicted CRP
sites in E. coli. We compare them with orthologous sites in Salmo-
nella typhimurium identified independently by CLUSTALW alignment,
and find a dependence of mutation probability on position in the
site. This dependence increases with predicted site binding energy.
The positions where mutation is most strongly suppressed are
those where mutation would have the biggest effect on predicted
binding energy. This finding suggests that many of the novel sites
are functional, that the matrix model correctly estimates their
binding strength, and that calculated CRP binding strength is the
quantity that is conserved between species. The analysis also
identifies many new E. coli binding sites and genes likely to be
functional for CRP.
The binding of transcription factors (TFs) to specific sites is acentral mechanism of transcriptional regulation (1). Power-
ful computational techniques for finding putative binding sites in
genomes and for characterizing TF binding on whole-genome
scales are becoming available (2–6). An energy matrix of size 4
L (where L is the site length) is often used to capture the binding
profile of a particular TF, under the simplifying assumption that
the contribution of a particular position in a binding site is
independent of neighboring positions (7–9). This assumption is
of unknown accuracy, and even if it is a good physical approx-
imation, the particular choice of energy matrix could be inade-
quate, leading to false identification of sites.
The cAMP response protein (CRP) is a dimeric DNA binding
and bending protein that binds in multiple Escherichia coli
promoters to 22-bp sites with a core consensus sequence GT-
GANNNNNNTCAC (10); the DPInteract database (11) con-
tains 48 such sites, and RegulonDB (12) contains more than 88.
Computational studies typically predict many more CRP binding
sites than are found in either of these databases (13–15).
Although the databases are certainly not complete, the apparent
large overprediction of binding sites undermines the credibility
of the matrix model of binding specificity on which these studies
are based. To sharpen the issue, we contrast the situation for
CRP with that for LacI, a TF that has a small number of known
binding sites and is thought to be highly specific. In fact, an
energy matrix that cleanly discriminates the known binding sites
from the rest of the genome can be found for LacI. To decide
whether CRP binding can successfully be described by a similar
matrix model, we need to know whether the overpredicted CRP
binding sites are functional. We look for evidence on this issue
by identifying partner sites in orthologous regions in Salmonella
typhimurium, a close relative of E. coli, and examining mutations
between site pairs. The mutation probability depends on position
in the site in a way that ensures rough conservation of CRP
binding energy between species. We take this as evidence that
the novel CRP sites have real biological function. We do not
know why experimental methods have not picked them up, but
the evidence that evolution cares about them is striking. We
conclude that the simple matrix model works as well for CRP as
for LacI, despite their very different binding profiles. We also
make specific predictions of many new CRP binding sites (and
regulated genes).
Methods
Genomes. We work with the genomes of E. coli K12 [National
Center for Biotechnology Information (NCBI) accession no.
NC004431, 4,639,221 bp] and S. typhimurium LT2 (NCBI ac-
cession no. NC003197, 4,857,432 bp). Genes and intergenic
regions are identified by comparison with protein tables avail-
able from NCBI. Genomes and tables are included in the
supporting information on the PNAS web site and at www.
princeton.educcallanbinding (see Software and Software
Availability).
Matrix Construction. A given TF contacts the genome at a site of
length L (of order 20 bp in typical bacterial examples). To
estimate the sequence-dependent affinity, we assign to each TF
a matrix b,i, which is used to score a site (b(i), i  1 . . . L)
according to the additive rule
E  
i1
L
bi,i.
We will refer to  as the energy matrix of the TF, and E is meant
to approximate the binding energy (in units of kT) of the TF to
the site. The usual method for constructing  (7) starts from a
list of known binding sites for a TF and applies the following
algorithm: for each position i in a site, the number of occurrences
Ni(b) of each DNA base b in the list of sites is counted, and the
matrix elements are assigned by the rule
bi  log
maxaNia 1
Nib 1
(see ref. 16). The 1 pseudocount regularizes the divergence
that arises if any of the Ni(a) happen to vanish in the finite
sample of known sites. The matrix is normalized to assign b,i 
0 to the most common base pair at site i and bi  0 to all others;
thus, the consensus sequence has E  0, and all others have E 
0. For an implementation of this algorithm, see the OPENFILL
program distributed with the software (see Software and Software
Availability). This method for assigning values to bi has a sound
physical and evolutionary rationale (7) when all of the input site
sequences have roughly the same binding energy to the TF.
When this is not the case, a more sophisticated algorithm may be
needed (a concrete example will be given shortly). In short, the
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validity of the matrix model is distinct from the validity of the
algorithm for evaluating the matrix itself.
The work reported here specifically concerns two TFs: CRP
and LacI. We used the known sites in the E. coli K12 genome as
listed in DPInteract (11). LacI contacts 21 bp and has three listed
binding sites (all in close proximity to the lac operon); CRP
contacts 22 bp and has 48 listed binding sites (widely dispersed
in the genome). Binding-site files suitable for use with the
OPENFILL program are available. These files include twice as
many sequences as cited above (i.e., 6 for LacI and 96 for CRP).
This is because CRP and LacI, like many bacterial TFs, are
symmetric dimers and can be regarded as reading either the top
or the bottom strand of the DNA. The two strand reads are not
usually identical and can legitimately be cited as independent site
data. However, as is appropriate for CRP and LacI, OPENFILL
creates a symmetrized energy matrix that assigns the same
energy to a sequence and its reverse complement (and therefore
to both reads of a site).
Binding-Site Search. Binding site search was done with the pro-
gram SCANGEN (see Software and Software Availability), which
takes as input the energy matrix for a TF, a genome, and a file
containing the bounding coordinates and names of all coding
regions in that genome (the latter two obtained from the NCBI
database as described above). The SCANGEN program assigns an
energy score to each site in the genome and produces two types
of output: cumulative histograms of number of binding sites
versus E value (both total number of sites and the number of sites
in noncoding regions) and a list of all sites below a chosen cutoff
E value, giving for each site its coordinate and, if located in a
noncoding region, the names of the flanking genes. The data
concerning location with respect to coding regions is a useful
diagnostic because functional sites are mostly located in non-
coding regions.
Orthology and Alignment of Intergenic Regions and Site Pairs. We
declare two intergenic regions to be orthologous if the flanking
genes in both E. coli and S. typhimurium have the same gene
names (according to the NCBI protein tables) and if the regions
align well with CLUSTALW (discussed below). The two genomes
have extensive orthology: there are 3,475 intergenic regions in E.
coli and 3,660 in S. typhimurium, of which 1,533 are orthologous
by this definition. This is a rather restrictive notion of orthology;
other workers (6, 17) find an additional 500 orthologous
intergenic regions based on orthology of downstream proteins.
With either definition, the mean difference rate (disregarding
end gaps) between orthologous intergenic region pairs is com-
parable (25%).
For an E. coli site lying in an intergenic region having an S.
typhimurium ortholog, we identify the sequence of the ortholo-
gous site by alignment of the relevant pair of intergenic regions.
We used CLUSTALW V.1.83 (18) to align intergenic region pairs,
keeping 30 bp of coding sequence on either side (typically a few
hundred base pairs of sequence in all); the default parameters for
CLUSTALW were used. The S. typhimurium sequence aligned to
the E. coli site is then defined to be its orthologous partner site,
provided that the alignment places no gaps in either sequence.
We place no limitation on the number of mutations between the
two sites.
Calculation of Expected Energy Change Under Mutation. We calcu-
late the expected energy change for a site by first calculating the
average rate of transitions and transversions for each region in
E. coli from the CLUSTALW alignment between the region and its
orthologous region in S. typhimurium. We adjust the rate of
transitions by a factor of two to account for null and back
mutations. Then, for each purine in the site we calculate the
expected energy change to be
ei  ptransition	epurinei
 ptransversion	epyrimidinei
,
where 	epurine
 and 	epyrimidine
 are the average contributions of a
purine and a pyrimidine at that position in the matrix. The
contribution of each pyrimidine is calculated similarly, and the
 e values are summed over all positions to calculate the total
expected change in energy. We did not introduce gapping into
our model because gaps in sites in either genome disqualify a site
for comparison and, moreover, occur infrequently (5% of the
aligned sequence consists of gaps).
Software and Software Availability. All software was developed in
C andor PYTHON 2.3 under LINUX. The software was devel-
oped ab initio by the authors; a package that can be used to
reproduce all of our results is available at www.princeton.edu
ccallanbinding. The software is copyright of Princeton Uni-
versity and the California Institute of Technology and is freely
available and redistributable under an Open Source-compatible
license.
Results
Binding Profiles of CRP and LacI Differ. LacI and CRP have very
different profiles: binding-site catalogs indicate that LacI has
three known sites in the immediate vicinity of the lac operon,
whereas CRP affects the transcription of many genes and has 48
listed sites. Although it may be too strong to say that LacI
regulates only the lac operon, it does seem clear that CRP affects
many more genes than LacI. Because it is not obvious that the
linear additive model for binding affinity can encompass both
extreme behaviors, a comparative study of these two cases should
be instructive.
We created energy matrices LacI-naive and CRP-naive by
using the known sites as described in Methods and then used
SCANGEN to create histograms of the energy distribution of all
sites in the E. coli genome. The results are presented in Tables
1 and 2. Each line gives the cumulative number of sites with E
less than the indicated cutoff, the cumulative percentage of sites
that are in genes, the cumulative percentage in intergenic
regions, and the cumulative number of the known (or input) sites
that have been captured. We count sites in coding and noncoding
regions separately because functional sites are expected to lie
Table 1. Sites isolated from the genome at several energy
cutoffs with LacI-naive, a matrix representing LacI binding
Cutoff No. of sites Coding, % Intergenic, % Known
3.00 1 0 100 13
5.00 2 50 50 23
7.00 26 85 15 33
9.00 483 86 14 33
The matrix was constructed from the three binding sites implicated in
transcriptional regulation of the lac operon. The mean (SD) of energy over all
sites in the genome is 20.9 (3.2).
Table 2. Sites isolated from the genome at several energy
cutoffs with CRP-naive, a matrix constructed from the list of 48
known CRP binding sites
Cutoff No. of sites Coding, % Intergenic, % Known
5.00 31 3 97 448
7.00 105 9 91 1048
9.00 375 26 74 2748
11.00 1,495 53 47 3948
15.00 26,873 72 28 4848
The mean (SD) of energy over all sites in the genome is 26.9 (4.8).
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mostly in the noncoding 15% of the E. coli genome and the
statistics of site location could convey useful evidence for or
against functionality.
The tables display a potential problem with the linear additive
model: using E value as the discriminant, the model seems to
overpredict the number of TF binding sites. For LacI, note that
although the top two bins in Table 1 capture only known sites,
the next bin captures the remaining known site in addition to 23
others. The novel sites, although competitive in E value, are
probably not true LacI sites because they are randomly located
in the genome, with no preference for noncoding regions. Even
so, the LacI-naive matrix discriminates the known sites from the
rest of the genome surprisingly well, given how few input data are
used. The situation for CRP, displayed in Table 2, is less good:
although the known sites are assigned small E values compared
to a random site in the genome, they have a large range in E
(E  12, or five orders of magnitude in calculated affinity) and
many sites not in the known site list have comparable or better
E values. Because CRP regulates many genes, it is less clear than
for LacI that the novel sites are spurious. In contrast to LacI, the
novel sites are not randomly distributed: the lower the E value,
the more likely they are to lie in noncoding regions. This finding
suggests that many of the novel CRP sites may be real. We will
develop other lines of evidence for this in what follows.
A Modified LacI Matrix Accurately Discriminates Known Sites. It is
important to understand whether the above problems are due to
a nonoptimal choice of the matrix or instead to a failure of the
linear additive model for sequence-dependent binding affinity.
To explore this, we also ran SCANGEN on two other matrices,
LacI-relax and CRP-relax, both derived by using a relaxation
method (C.T.B. and C.G.C., unpublished work). The relaxation
method takes as input the known sites and their relative binding
affinities (if known) as well as the background genome. The use
of the relative binding affinities is crucial: it has the effect that
the sequences of subsidiary weak binding sites, should any exist,
can be used as input data to refine the matrix without destabi-
lizing it. The relaxation implements the notion that for proper
function, not only must binding to the known sites be strong, but
net binding to the rest of the genome must be small. The matrices
produced by this method differ significantly from the ‘‘naive’’
matrices and lead to the site histograms displayed in Tables 3 and
4 (the matrices used are available on-line as discussed in Software
and Software Availability).
Comparing Table 3 with Table 1, we see that LacI-relax, in
contrast with LacI-naive, succeeds in creating a gap in energy
between the known sites and the rest of the genome, thus
realizing the picture that LacI acts primarily on the lac operon.
This is not a prediction, just the (nontrivial) statement that a
linear model matrix that fits the qualitative facts about LacI can
be found. Whether this matrix correctly predicts finer details like
the affinity distribution of weaker (presumably nonfunctional)
sites below the gap is an interesting question. If other genes than
the lac operon were to be found to be regulated by LacI, this
discussion would have to be revisited.
Table 4 shows the result of an attempt to improve the matrix
for CRP by a similar relaxation method: apart from a possible
rescaling of the E value, Table 4 looks similar to Table 2. In both
tables, the known sites span a wide range of E values and are
accompanied by a large number of novel sites of comparable E
values. In what follows, we will look for evidence concerning the
functionality of these sites via interspecies comparisons. This is
important because, if the novel sites are spurious, it will be hard
to avoid concluding that the linear additive energy model fails as
a framework for predicting functionality, at least for CRP.
Because relaxation did not have much effect, we will revert to
assessing CRP sites by using the matrix CRP-naive.
Novel CRP Sites Have Similar Binding Energies in S. typhimurium. To
assess the status of the novel E. coli sites found by the CRP
energy matrix, we performed comparisons with orthologous sites
in the closely related organism S. typhimurium. Partners of
strong E. coli sites lying in intergenic regions are constructed by
alignment of the orthologous S. typhimurium intergenic region
(see Methods). Because the CRP energy matrix is not used in
generating the alignment, we have no reason to expect the
aligned sites in S. typhimurium to be scored as strong binding
sites. (Note that S. typhimurium CRP differs from E. coli CRP
in only one of 210 aa and can be expected to have the same
sequence-specific binding affinity.)
What actually happens is shown in Fig. 1 where we compare
the energy of strong CRP sites in E. coli with the energy of
orthologous sites in S. typhimurium. The graph shows the line of
equality (no mutations), a scatter plot of the actual orthologous
pair energies (actual mutations), and a scatter plot of the same
sites with the S. typhimurium site energy replaced by its expected
value under random mutations. Actual mutated energies lie well
below what is expected on the random mutation model for E. coli
site energies up to E  7 (and a population difference exists up
to higher values of site energy). The fixation of energy is not due
to a general suppression of mutation: for the 34 site pairs with
Table 3. Site list for LacI-relax, a matrix constructed to pick out
known LacI sites preferentially
Cutoff No. of sites Coding, % Intergenic, % Known
3.00 1 0 100 13
5.00 1 0 100 13
7.00 3 33 67 33
9.00 7 71 29 33
Note that two of the three known LacI binding sites are located in coding
regions.
Table 4. Site list for CRP-relax, a matrix constructed to pick out
known CRP sites preferentially
Cutoff No. of sites Coding, % Intergenic, % Known
5.00 103 10 90 1148
7.00 524 38 62 3348
9.00 3,545 66 34 4348
11.00 21,386 74 26 4848
15.00 275,384 79 21 4848
Fig. 1. Binding energy is strongly correlated between orthologous site pairs.
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E. coli site energy less than 7.0, the average number of mutations
per site is 4.1, not very different from the background rate of 5.5
for 22-bp sequences. The actual number of mutations per site
runs from 0 to 11, and highly mutated sequences often have
nearly the same energy (in one case, 7 of 22 positions are
mutated, yet the change in E is only 0.22). The conservation of
CRP binding energy (as distinct from sequence conservation)
suggests that these sites are functional for CRP in some way
useful to the organism.
Novel CRP Site Pairs Have Strongly Biased Mutational Patterns. The
most striking evidence of conservation is obtained by computing
population averages of the position dependence of the proba-
bility of mutation (20). We did this for populations of ortholo-
gous site pairs defined by several energy cutoffs. The results,
displayed in Fig. 2, show a strong positional bias within the site
(the data have been reflected about the center position to
smooth out statistical noise). The bias washes out abruptly when
the cutoff exceeds Ecut  11. This is beyond the energy where,
according to Fig. 1, the close correlation between individual site
energies in the two species begins to wash out.
For all cutoffs, novel sites greatly outnumber input sites. Thus,
the positional bias in mutation frequency is a property of the
novel sites. The same analysis for the input sites alone (38 of the
48 input sites have S. typhimurium orthologs) gives a result
indistinguishable from the Ecut  9 curve in Fig. 2 (see support-
ing information). The positional bias in mutation frequency is
essentially the same for the novel sites and the input sites and
presumably has a common cause.
The positional bias has the shape expected if the sites are
constrained to strongly bind a dimeric TF in both species. For
example, only two of the site pairs found with Ecut  5 have even
a single mutation in the core positions 4–7 and their comple-
ments at positions 14–17. This pattern of fixation suggests that
these eight bases dominate the site energy, consistent with the
usual picture of a core region of the TF contacting the DNA and
selecting a central motif. An examination of the CRP-naive
matrix does show that these positions should be the most strongly
fixed. We emphasize that the S. typhimurium sites were chosen
with no consideration of their CRP binding energy: the nonran-
dom pattern of the mutations between them and their E. coli
orthologs is evidence that some biologically meaningful aspect of
the site sequence is being conserved. A plausible interpretation
is that the sites are functional and that their CRP binding energy
is approximately conserved.
Fig. 2 also confirms that the correlation of binding energies
between E. coli and S. typhimurium shown in Fig. 1 is not due to
strict sequence conservation: in the population of sites with Ecut
 7, only 8 of the 22 bases have a mutation rate of5%, whereas
the 14 remaining bases vary at a rate of 18% or higher. The total
number of mutations between orthologous site sequences is
often large, and it would be difficult to identify the orthologous
pairs by looking for local patches of stronger-than-background
sequence conservation.
Flanking Bases Are Required for Discrimination Ability. The pattern
of base fixation shown in Fig. 2 suggests that there is a strong
constraint on eight core positions within each site. This raises the
question whether the flanking sequence lends useful discrimi-
natory ability. To study this, we constructed a CRP-core-only
matrix from CRP-naive by setting to zero all of the entries in the
rows corresponding to the 14 flanking positions. The site energy
histogram produced by scanning the E. coli genome with this
modified matrix is given in Table 5. The high-scoring sites clearly
constitute a very different population from the high-scoring sites
under the CRP-naive matrix. There are many ways to see this, but
an examination of the sites in the first bin (E  1) makes the
point: these sites all have E  0, i.e., they match the consensus
sequence for the eight core positions. But half of these ‘‘perfect’’
sites lie in coding regions, whereas the sites that our evolutionary
analysis suggests are under control of CRP are very heavily
concentrated in the noncoding regions. The situation gets pro-
gressively worse for higher cutoffs. We conclude that the core-
only matrix cannot sharply discriminate the sites of interest.
Individual f lanking positions contribute limited information but,
taken together, they dramatically enhance the ability of the
matrix to discriminate functional sites (or at least the sites shown
by our evolutionary comparison to be under control of CRP). An
evolutionary analysis of the population of sites that bind strongly
according to CRP-core-only and also lie in coding regions is
instructive: no significant position-dependent mutation pattern
is seen, further confirming that these sites are spurious (see
supporting information).
Discussion
Novel CRP Sites Are Probably Functional. Attempts to describe the
sequence-specific DNA binding affinity of CRP by a linear
additive energy model always lead to the prediction of many
more strong binding sites (and regulated genes and operons)
than are verified by direct experimental methods. We used the
DPInteract site compendium (11) to demonstrate this, but the
same conclusion would have been reached had we used other
databases such as RegulonDB (12) (see supporting information).
It is important to obtain independent information about the
status of the many predicted novel binding sites: if they are
spurious, the validity of the linear additive binding energy model
is called into question; if they are real, the validity of that model
is reaffirmed in a challenging context, and something new is
learned about how CRP functions.
This issue could in principle be addressed experimentally,
Fig. 2. Paired site populations show a position-dependent pattern of mu-
tation rates.
Table 5. Scangen list for CRP binding, using a matrix modified to
ignore contributions from any but the eight core base pairs of
the site
Cutoff No. of sites Coding, % Intergenic, % Known
1.00 166 51 49 70375
3.00 2508 82 18 217375
5.00 17,411 86 14 325375
7.00 78,995 86 14 372375
9.00 271,661 86 14 375375
The list of known sites in this table is chosen as all those sites that score with
an energy of 9 or less using CRP-naive (see Fig. 2).
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although that approach has drawbacks: in vivo tests may fail to
expose the role of a given CRP motif because the test conditions
are incorrect, and in vitro tests such as gel shifts or DNase
footprinting can score pseudosites as functional CRP binding
sites. We have instead sought evidence of their functionality via
a computational study of binding-site evolution between closely
related bacterial species. We have presented several lines of
evidence suggesting that the novel sites are mostly functional,
with a likelihood that increases with the strength of the predicted
binding (as measured by the CRP energy matrix). They are, in
increasing order of importance, as follows:
1. The novel CRP sites are overwhelmingly located in noncoding
regions, exactly where regulatory sites should lie. Because the
E. coli genome is only 15% noncoding and because spurious
sites should be randomly located, this is an improbable chance
occurrence. This observation is independent of evolutionary
considerations.
2. If a novel strong E. coli site lies in an intergenic region with
an S. typhimurium ortholog, an orthologous site pair can be
defined by aligning the two regions. The difference in pre-
dicted binding energy between the two sites is systematically
less than would be expected on the hypothesis of random
mutations.
3. Within a population of orthologous pairs of novel strong
binding sites, the probability of mutation depends strongly on
position within the site; random mutations would have led to
a position-independent profile. The actual position-
dependent pattern is consistent with the way CRP is known
to contact the DNA.
The cross-species comparison shows that populations of or-
thologous sites defined by strong predicted CRP binding energy
have a nonrandom mutation pattern consistent with conserva-
tion of CRP binding energy. Conservation makes sense if the
sites are functional for CRP and this evidence suggests that the
primary determinant of functionality is the CRP binding energy
of the site sequence. We have focused on sites with orthologs, but
that was a device to select a subpopulation of sites on which
functionality could be observed via its effect on mutations.
Therefore, although the evolutionary evidence applies directly
only to sites with orthologs, we suggest that strong sites in
intergenic regions without orthologs are also likely to be func-
tional for CRP.
The specific outcome of these considerations is a list of
computational predictions of novel CRP binding sites in E. coli.
We include all sites with E  9 (the cutoff at which the mutation
profile of the site pair population becomes indistinguishable
from that of the starting databases; see supporting information)
whether or not they have a companion species ortholog. A short
list, generated with the stringent cutoff E  4, is given in Table
6. The long list, containing 190 novel sites, is available on-line
(see Software and Software Availability). The genes downstream
from these sites would be interesting targets for investigation of
the influence of CRP on their expression levels. The new genes
do not, by and large, appear in the most comprehensive data-
bases of regulatory information (see supporting information),
suggesting that their regulation by CRP is subtle. On the other
hand, the evolutionary evidence that such effects are important
to the organism is strong. Understanding how and why will be an
enlightening enterprise.
Binding Energy, Not Sequence, Is Conserved. Fig. 1 shows that the
binding energies of sites in E. coli correlate well with the binding
energy of independently aligned sites in S. typhimurium. Fig. 2
shows that this is not, however, due to strict sequence conser-
vation: outside the eight core positions, the individual site pairs
differ significantly at the sequence level. Others (19) have also
noted the position-dependent mutation rate between ortholo-
gous binding sites. We have observed that this position depen-
dence becomes more and more pronounced as the binding
energy computed from the CRP-naive matrix becomes stronger.
This finding suggests that the underlying cause of the mutation
pattern is conservation of site binding energy between the two
species. It also suggests that the matrix model binding energy is
closely related to the actual in vivo binding energy. This agrees
with the prediction made by Berg and von Hippel (16) on
theoretical grounds.
Lessons for Practical Motif Hunting. Whereas these observations are
useful for considering the actual nature of genomic binding of
TFs, we can also try to draw some conclusions regarding the
utility of various types of computational searches for novel TF
binding sites on a whole-genome scale.
A promising technique for locating functional regulatory
regions de novo identifies as putative binding sites elements of
genomic sequence conserved between two or more closely
related species (6, 20). However, we have found that sites may
diverge at the sequence level without significantly changing the
binding energy, as shown in Figs. 1 and 2. Indeed, our compar-
isons of E. coli and aligned S. typhimurium regions containing
predicted CRP binding sites suggest that many of the sites would
not be identifiable on the basis of local sequence conservation.
Another prevalent technique for binding site searches is to use
a ‘‘consensus sequence,’’ consisting of the bases that appear most
frequently in the list of known sites. In the case of CRP, searches
for even the very general consensus sequence GT-
GANNNNNNTCAC would fail to discriminate between our
novel (putatively functional) sites and nonfunctional sites, be-
cause of the lack of weighting from the flanking sequence.
Searches with more restricted sequences would necessarily re-
cover only a subset of our novel sites.
These observations suggest that a full matrix model will be
needed to give optimum discrimination in separating actual
binding sites from the rest of the genome. Unfortunately, there
is usually only a limited number of known sequences from which
to infer the matrix and a large error in its construction. Our
results suggest that statistics could be improved by using aligned
sites from orthologous intergenic regions as additional inputs.
Beyond that, it may be fruitful to pursue optimization methods
for tuning matrices to better represent TF binding. The results
of using one such method (developed by us in unpublished work)
Table 6. List of genes with putative CRP sites upstream of
the operon
Upstream site Downstream gene(s) Aligned site
2.59 tsr (b4355); yjiY (b4354) —
2.63 b1904 (b1904) —
3.14 yjcB (b4060); yjcC (b4061) 3.33
3.19 nupG (b2964) 9.14
3.42 mtlA (b3599); yibI (b3598) —
3.43 b1458 (b1458) —
3.49 tnaL (b3707) —
3.66 qseA (b3243); yhcR (b3242) —
3.74 yeaA (b1778); b1777 (b1777); gapA (b1779) 5.87
3.77 ydeA (b1528) —
3.77 hpt (b0125); ged (b0124) 4.47
3.83 yefQ (b1111); ycfR (b1112) 6.70
3.87 proP (b4111) —
3.94 ygiG (b3073); aer (b3072) —
An energy cutoff of 4.0 was used. Where an orthologous site exists in S.
typhimurium, the energy of that site is also given. An extended list is available
on our web site (see Software and Software Availability).
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to improve the LacI energy matrix were presented earlier in the
paper. An independent study of CRP binding in E. coli that uses
an optimization procedure (QPMEME) to refine the energy
matrix has recently appeared (15). It also finds many novel
predicted CRP sites and addresses the issue of whether they are
real on the basis of their positions relative to transcription
initiation sites. The quite interesting results of applying our
species comparison assessment of functionality to the QPMEME
site list are presented in the supporting information.
Concluding Remarks. We have demonstrated that many compu-
tationally identified CRP binding sites have nonrandom muta-
tion patterns, strongly suggesting that they are functional. Sites
that have strong predicted binding energy but no ortholog in S.
typhimurium are also likely to be actual CRP sites, although our
method gives no direct evidence of their functionality. Com-
bined, we find that there are190 novel CRP binding sites in the
E. coli genome, none of them known from experimental evi-
dence. Although this is important information about CRP itself,
we would like to emphasize the equally important conclusion
that the linear energy matrix model for TF binding works well in
a case where it had been thought to generate far too many false
positives. It will be interesting to explore this issue across a wider
range of TFs and organisms.
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